Differential toxicity, conformation and morphology of typical initial aggregation states of Aβ1-42 and Aβpy3-42

Denise Galante1, Alessandro Corsaro, Tullio Florio

  • 1Institute for Macromolecular Studies, National Research Council, 16149 Genova, Italy.

Insights

Amyloid-beta peptide (Aβ) aggregation is central to Alzheimer's disease. This study reveals that Aβpy3-42, a modified Aβ peptide, exhibits distinct aggregation states and higher neurotoxicity compared to standard Aβ1-42.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Molecular Biology

Background:

  • Alzheimer's disease pathogenesis involves amyloid-beta (Aβ) peptides, particularly Aβ1-42.
  • Modified Aβ peptides, such as Aβpy3-42, are implicated due to their unique properties.
  • Understanding the structural characteristics and toxicity of different Aβ aggregation states is crucial.

Purpose of the Study:

  • To characterize the structural features of different aggregation states of Aβ1-42 and Aβpy3-42.
  • To evaluate and compare the neurotoxicity of these distinct Aβ aggregates.
  • To elucidate the role of Aβpy3-42 in Alzheimer's disease pathogenesis.

Main Methods:

  • Separation of Aβ1-42 and Aβpy3-42 aggregates (small, medium, large) using fast protein liquid chromatography.
  • Structural analysis via circular dichroism, atomic force microscopy (AFM), and transmission electron microscopy (TEM).
  • Neurotoxicity assessment using human neuroblastoma SH-SY5Y cells (MTT reduction, xCELLigence, Annexin V binding) and confocal immunofluorescence microscopy for internalization studies.

Main Results:

  • Aβ aggregates exhibited distinct structural conformations (random coil vs. β-sheet) and morphologies.
  • Aβ1-42's large aggregates (la) were most toxic, while Aβpy3-42's small (sa) and large (la) aggregates showed equal, potent toxicity.
  • Aβpy3-42 aggregates were internalized more efficiently by neuronal cells, correlating with their higher toxicity.

Conclusions:

  • Aβpy3-42 exhibits unique aggregation properties and enhanced neurotoxicity compared to Aβ1-42.
  • Specific intermediate aggregation states of Aβ peptides are key drivers of neurotoxicity.
  • These findings highlight Aβpy3-42's significant role in Alzheimer's disease pathogenesis.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...